A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma-Reference-Cited by-同舟云学术

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma

Published:2011-07 Issue:7 Volume:17 Page:987-994
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Srivastava Shivani,Jones David,Wood Lisa L.,Schwartz Jennifer E.,Nelson Robert P.,Abonour Rafat,Secrest Angie,Cox Elizabeth,Baute Jay,Sullivan Cheryl,Kane Kathleen,Robertson Michael J.,Farag Sherif S.

Funder

Institutional

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference32 articles.

1. Bone marrow transplantation;Armitage;N Engl J Med,1994

2. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma;Philip;N Engl J Med,1987

3. Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin’s lymphoma;Copelan;Bone Marrow Transplant,2000

4. Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin’s lymphoma;Robertson;Leuk Lymphoma,2005

5. The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial;Stiff;Biol Blood Marrow Transplant,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Роль полиморфных вариантов генов цитохромов Р450, а также генов GSTP1 и MDR1 в развитии токсических осложнений при проведении программной противоопухолевой лекарственной терапии у пациентов с классической лимфомой Ходжкина;Clinical Oncohematology;2024-04-01

2. A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma;Bone Marrow Transplantation;2022-04-07

3. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer;BMC Cancer;2021-07-05

4. The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis;Mediators of Inflammation;2020-12-07

5. Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer;2020-08-21